Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis

Article Abstract:

The Arthritis, Rheumatism, and Aging Medical Information System (ARAMIS) is a good model for a chronic disease database that can be used to evaluate treatments. Since 1976, ARAMIS has collected detailed information on 6,673 rheumatoid arthritis patients with over 50,000 patient-years of follow-up.

Models, Information services, Cost benefit analysis, Registries (in medicine), Registries (Medicine)

---

Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment

Article Abstract:

The drug infliximab appears to be effective in the treatment of rheumatoid arthritis. This drug is a monoclonal antibody that blocks the activity of tumor necrosis factor, a protein produced by the immune system that has been implicated in the development of rheumatoid arthritis.

Health aspects, Monoclonal antibodies, Tumor necrosis factor

---

Similar abstracts:

• Abstracts: Chest pain in patients with rheumatoid arthritis. Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing
• Abstracts: Diagnosis of fetal rubella infection with reverse transcription and nested polymerase chain reaction: a study of 34 cases diagnosed in fetuses
• Abstracts: The care programme approach: a patient perspective. Fitness to practise in community mental health. Telling it like it is
• Abstracts: Anti-HIV potential of a new interferon, interferon-tau (trophoblastin). Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS
• Abstracts: Effect of whole-body hyperthermia on AIDS patients with Kaposi's sarcoma: a pilot study. part 2 Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcoma

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.